Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness

Published:2021-08-16 Issue:11 Volume:20 Page:1299-1307
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Mechineni Ashesha¹^ORCID,Kassab Hagar²^ORCID,Manickam Rajapriya³^ORCID

Affiliation:

1. Department of Pulmonary and Critical Care Medicine,St.Joseph’University Medical Center,Paterson, NJ, USA

2. Department of Internal Medicine, St Joseph University Medical Center, Paterson, NJ, USA

3. Department of Pharmacy, St Joseph University Medical Center, Paterson, NJ, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1962284

Reference57 articles.

1. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

2. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

3. World Health Organization [Internet]. Clinical management of COVID-19. interim guidance. 2020.

4. Lo MK, Jordan R, Arvey A, et al. GS-5734 and its parent nucleoside analog inhibit Filo- Pneumo- and Paramyxoviruses. Sci Rep 7, 43395 (2017)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends of drug expenditure in Taiwan National Health Insurance before and during COVID-19 pandemic;Frontiers in Medicine;2024-08-20

2. A perspective current and past modes of inhalation therapy;Microbial Biotechnology;2024-02

3. A Critical Assessment of Remdesivir;Current Drug Therapy;2023-10-31

4. Thuja occidentalis: An Unexplored Phytomedicine with Therapeutic Applications;Combinatorial Chemistry & High Throughput Screening;2023-01

5. Machine learning models for predicting severe COVID-19 outcomes in hospitals;Informatics in Medicine Unlocked;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3